Shares of Regeneron Pharmaceuticals Inc.
REGN,
+0.88%
gained 2.1% in premarket trading on Wednesday, the day after the company said the U.S. government had purchased an additional 1.4 million doses of its monoclonal antibody treatment for COVID-19 for…
